Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies
- PMID: 23095910
- DOI: 10.1097/ACI.0b013e3283588ca6
Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies
Abstract
Purpose of review: This review discusses the strengths and challenges of using whole genome sequencing (WGS)/whole exome sequencing (WES) for identifying novel genetic causes of primary immunodeficiencies.
Recent findings: WGS permits comprehensive sequencing of introns and exons, whereas WES allows deeper sequencing of exonic regions at a lower cost. Due to the large number of genetic variants found in each genome, it is necessary to use filtering approaches to distinguish deleterious from benign variants. WES has been used successfully to identify novel genetic causes of primary immunodeficiency. Complex structural variations and non-Mendelian disorders remain challenges for WGS/WES.
Summary: WGS/WES is a powerful screening tool with great potential to identify genetic causes of primary immunodeficiencies for research and clinical applications. To use WGS/WES effectively, it is necessary to understand how to filter the sequencing data and to realize its limitations as well as its strengths.
Similar articles
-
Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5473-8. doi: 10.1073/pnas.1418631112. Epub 2015 Mar 31. Proc Natl Acad Sci U S A. 2015. PMID: 25827230 Free PMC article.
-
Exome versus transcriptome sequencing in identifying coding region variants.Expert Rev Mol Diagn. 2012 Apr;12(3):241-51. doi: 10.1586/erm.12.10. Expert Rev Mol Diagn. 2012. PMID: 22468815 Review.
-
Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?J Med Genet. 2014 Jan;51(1):68-70. doi: 10.1136/jmedgenet-2013-101934. Epub 2013 Sep 27. J Med Genet. 2014. PMID: 24078715
-
Clinical sequencing: is WGS the better WES?Hum Genet. 2016 Mar;135(3):359-62. doi: 10.1007/s00439-015-1631-9. Epub 2016 Jan 7. Hum Genet. 2016. PMID: 26742503 Free PMC article.
-
What can exome sequencing do for you?J Med Genet. 2011 Sep;48(9):580-9. doi: 10.1136/jmedgenet-2011-100223. Epub 2011 Jul 5. J Med Genet. 2011. PMID: 21730106 Review.
Cited by
-
Use of Genetic Testing for Primary Immunodeficiency Patients.J Clin Immunol. 2018 Apr;38(3):320-329. doi: 10.1007/s10875-018-0489-8. Epub 2018 Apr 19. J Clin Immunol. 2018. PMID: 29675737 Review.
-
Whole genome sequencing identifies novel structural variant in a large Indian family affected with X-linked agammaglobulinemia.PLoS One. 2021 Jul 12;16(7):e0254407. doi: 10.1371/journal.pone.0254407. eCollection 2021. PLoS One. 2021. PMID: 34252140 Free PMC article.
-
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy.Front Immunol. 2025 Jan 7;15:1490035. doi: 10.3389/fimmu.2024.1490035. eCollection 2024. Front Immunol. 2025. PMID: 39845971 Free PMC article. Review.
-
Great challenges in pediatrics.Front Pediatr. 2013 Mar 7;1:5. doi: 10.3389/fped.2013.00005. eCollection 2013. Front Pediatr. 2013. PMID: 24400252 Free PMC article. No abstract available.
-
Overview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseases.Circ Res. 2013 Jun 7;112(12):1613-23. doi: 10.1161/CIRCRESAHA.113.300939. Circ Res. 2013. PMID: 23743227 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials